Varying importance of soluble and membrane CD14 in endothelial detection of lipopolysaccharide

Journal of Immunology

Volumn 181, Issue 2, 2008, Pages 1446-1453

  Lloyd Jones, Katie L ^a   Kelly, Margaret M ^a   Kubes, Paul ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CD14 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD14; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 2; UNCLASSIFIED DRUG; MYD88 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TICAM2 PROTEIN, HUMAN;

ANTIGEN FUNCTION; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; HUMAN; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; ANIMAL; BLOOD; CELL CULTURE; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; TUMOR CELL LINE; VASCULAR ENDOTHELIUM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, CD14; CELL LINE, TUMOR; CELLS, CULTURED; E-SELECTIN; ENDOTHELIUM, VASCULAR; HUMANS; LIPOPOLYSACCHARIDES; MICE; MICE, MUTANT STRAINS; MYELOID DIFFERENTIATION FACTOR 88;

EID: 49049107204     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.2.1446     Document Type: Article

References (41)

1. Bazil, V., V. Horejsi, M. Baudys, H. Kristofova, J. L. Strominger, W. Kostka, and I. Hilgert. 1986. Biochemical characterization of a soluble form of the 53-kDa monocyte surface antigen. Eur. J. Immunol. 16: 1583-1589. (Pubitemid 17025700)
2. Haziot, A., S. Chen, E. Ferrero, M. G. Low, R. Silber, and S. M. Goyert. 1988. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J. Immunol. 141: 547-552. (Pubitemid 18210257)
3. Simmons, D. L., S. Tan, D. G. Tenen, A. Nicholson-Weller, and B. Seed. 1989. Monocyte antigen CD14 is a phospholipid anchored membrane protein. Blood 73: 284-289.
4. Frey, E. A., D. S. Miller, T. G. Jahr, A. Sundan, V. Bazil, T. Espevik, B. B. Finlay, and S. D. Wright. 1992. Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176: 1665-1671.
5. Golenbock, D. T., R. R. Bach, H. Lichenstein, T. S. Juan, A. Tadavarthy, and C. F. Moldow. 1995. Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells. J. Lab. Clin. Med. 125: 662-671.
6. Haziot, A., G. W. Rong, J. Silver, and S. M. Goyert. 1993. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J. Immunol. 151: 1500-1507. (Pubitemid 23219288)
7. Pugin, J., C. C. Schurer-Maly, D. Leturcq, A. Moriarty, R. J. Ulevitch, and P. S. Tobias. 1993. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA 90: 2744-2748. (Pubitemid 23113493)
8. Read, M. A., S. R. Cordle, R. A. Veach, C. D. Carlisle, and J. Hawiger. 1993. Cell-free pool of CD14 mediates activation of transcription factor NF-κB by lipopolysaccharide in human endothelial cells. Proc. Natl. Acad. Sci. USA 90: 9887-9891. (Pubitemid 23328215)
9. Jersmann, H. P., C. S. Hii, G. L. Hodge, and A. Ferrante. 2001. Synthesis and surface expression of CD14 by human endothelial cells. Infect. Immun. 69: 479-485. (Pubitemid 32038347)
10. Lloyd, K. L., and P. Kubes. 2006. GPI-linked endothelial CD14 contributes to the detection of LPS. Am. J. Physiol. 291: H473-H481.
11. Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115-122.
12. Kawai, T., O. Takeuchi, T. Fujita, J. Inoue, P. F. Muhlradt, S. Sato, K. Hoshino, and S. Akira. 2001. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167: 5887-5894. (Pubitemid 33062783)
13. Takeuchi, O., K. Takeda, K. Hoshino, O. Adachi, T. Ogawa, and S. Akira. 2000. Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades. Int. Immunol. 12: 113-117. (Pubitemid 30045418)
14. Yamamoto, M., S. Sato, H. Hemmi, K. Hoshino, T. Kaisho, H. Sanjo, O. Takeuchi, M. Sugiyama, M. Okabe, K. Takeda, and S. Akira. 2003. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301: 640-643. (Pubitemid 36927946)
15. Fitzgerald, K. A., D. C. Rowe, B. J. Barnes, D. R. Caffrey, A. Visintin, E. Latz, B. Monks, P. M. Pitha, and D. T. Golenbock. 2003. LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the Toll adapters TRAM and TRIF. J. Exp. Med. 198: 1043-1055.
16. Oshiumi, H., M. Sasai, K. Shida, T. Fujita, M. Matsumoto, and T. Seya. 2003. TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to Toll-like receptor 4 TICAM-1 that induces interferon-β. J. Biol. Chem. 278: 49751-49762. (Pubitemid 37548808)
17. Hoebe, K., E. M. Janssen, S. O. Kim, L. Alexopoulou, R. A. Flavell, J. Han, and B. Beutler. 2003. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat. Immunol. 4: 1223-1229. (Pubitemid 37540691)
18. Saito, S., M. Matsuura, K. Tominaga, T. Kirikae, and M. Nakano. 2000. Important role of membrane-associated CD14 in the induction of IFN-β and subsequent nitric oxide production by murine macrophages in response to bacterial lipopolysaccharide. Eur. J. Biochem. 267: 37-45. (Pubitemid 30029735)
19. Jiang, Z., P. Georgel, X. Du, L. Shamel, S. Sovath, S. Mudd, M. Huber, C. Kalis, S. Keck, C. Galanos, et al. 2005. CD14 is required for MyD88-independent LPS signaling. Nat. Immunol. 6: 565-570. (Pubitemid 41710726)
20. Harari, O. A., P. Alcaide, D. Ahl, F. W. Luscinskas, and J. K. Liao. 2006. Absence of TRAM restricts Toll-like receptor 4 signaling in vascular endothelial cells to the MyD88 pathway. Circ. Res. 98: 1134-1140.
21. Andonegui, G., S. M. Kerfoot, K. McNagny, K. V. Ebbert, K. D. Patel, and P. Kubes. 2005. Platelets express functional Toll-like receptor-4. Blood 106: 2417-2423. (Pubitemid 41510815)
22. Andreakos, E., S. M. Sacre, C. Smith, A. Lundberg, S. Kiriakidis, T. Stonehouse, C. Monaco, M. Feldmann, and B. M. Foxwell. 2004. Distinct pathways of LPS-induced NF-κB activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP. Blood 103: 2229-2237. (Pubitemid 38326242)
23. Silva, C., K. Zhang, S. Tsutsui, J. K. Holden, M. J. Gill, and C. Power. 2003. Growth hormone prevents human immunodeficiency virus-induced neuronal p53 expression. Ann. Neurol. 54: 605-614. (Pubitemid 37346067)
24. Landmann, R., S. Link, S. Sansano, Z. Rajacic, and W. Zimmerli. 1998. Soluble CD14 activates monocytic cells independently of lipopolysaccharide. Infect. Immun. 66: 2264-2271. (Pubitemid 28194129)
25. Sacre, S. M., A. M. Lundberg, E. Andreakos, C. Taylor, M. Feldmann, and B. M. Foxwell. 2007. Selective use of TRAM in lipopolysaccharide (LPS) and lipoteichoic acid (LTA) induced NF-κB activation and cytokine production in primary human cells: TRAM is an adaptor for LPS and LTA signaling. J. Immunol. 178: 2148-2154.
26. Wurfel, M. M., B. G. Monks, R. R. Ingalls, R. L. Dedrick, R. Delude, D. Zhou, N. Lamping, R. R. Schumann, R. Thieringer, M. J. Fenton, et al. 1997. Targeted deletion of the lipopolysaccharide (LPS)-binding protein gene leads to profound suppression of LPS responses ex vivo, whereas in vivo responses remain intact. J. Exp. Med. 186: 2051-2056.
27. Triantafilou, M., K. Triantafilou, and N. Fernandez. 2000. Rough and smooth forms of fluorescein-labelled bacterial endotoxin exhibit CD14/LBP dependent and independent binding that is influenced by endotoxin concentration. Eur. J. Biochem. 267: 2218-2226. (Pubitemid 30220066)
28. Triantafilou, K., M. Triantafilou, and R. L. Dedrick. 2001. A CD14-independent LPS receptor cluster. Nat. Immunol. 2: 338-345.
29. Cohen, L., A. Haziot, D. R. Shen, X. Y. Lin, C. Sia, R. Harper, J. Silver, and S. M. Goyert. 1995. CD14-independent responses to LPS require a serum factor that is absent from neonates. J. Immunol. 155: 5337-5342.
30. Lynn, W. A., Y. Liu, and D. T. Golenbock. 1993. Neither CD14 nor serum is absolutely necessary for activation of mononuclear phagocytes by bacterial lipopolysaccharide. Infect. Immun. 61: 4452-4461.
31. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249: 1431-1433. (Pubitemid 20341908)
32. Haziot, A., E. Ferrero, F. Kontgen, N. Hijiya, S. Yamamoto, J. Silver, C. L. Stewart, and S. M. Goyert. 1996. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity 4: 407-414. (Pubitemid 26174055)
33. Haziot, A., X. Y. Lin, F. Zhang, and S. M. Goyert. 1998. The induction of acute phase proteins by lipopolysaccharide uses a novel pathway that is CD14-independent. J. Immunol. 160: 2570-2572. (Pubitemid 28136705)
34. Perera, P. Y., S. N. Vogel, G. R. Detore, A. Haziot, and S. M. Goyert. 1997. CD14-dependent and CD14-independent signaling pathways in murine macrophages from normal and CD14 knockout mice stimulated with lipopolysaccharide or Taxol. J. Immunol. 158: 4422-4429.
35. van Deventer, S. J., H. R. Buller, J. W. ten Cate, A. Sturk, and W. Pauw. 1988. Endotoxaemia: an early predictor of septicaemia in febrile patients. Lancet 1: 605-609.
36. Kim, H. M., B. S. Park, J. I. Kim, S. E. Kim, J. Lee, S. C. Oh, P. Enkhbayar, N. Matsushima, H. Lee, O. J. Yoo, and J. O. Lee. 2007. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130: 906-917.
37. Visintin, A., K. A. Halmen, E. Latz, B. G. Monks, and D. T. Golenbock. 2005. Pharmacological inhibition of endotoxin responses is achieved by targeting the TLR4 coreceptor, MD-2. J. Immunol. 175: 6465-6472. (Pubitemid 41598888)
38. Wang, P. Y., R. L. Kitchens, and R. S. Munford. 1995. Bacterial lipopolysaccharide binds to CD14 in low-density domains of the monocyte-macrophage plasma membrane. J. Inflamm. 47: 126-137. (Pubitemid 27057415)
39. Pugin, J., V. V. Kravchenko, J. D. Lee, L. Kline, R. J. Ulevitch, and P. S. Tobias. 1998. Cell activation mediated by glycosylphosphatidylinositol- anchored or transmembrane forms of CD14. Infect. Immun. 66: 1174-1180. (Pubitemid 28101162)
40. Rowe, D. C., A. F. McGettrick, E. Latz, B. G. Monks, N. J. Gay, M. Yamamoto, S. Akira, L. A. O'Neill, K. A. Fitzgerald, and D. T. Golenbock. 2006. The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction. Proc. Natl. Acad. Sci. USA 103: 6299-6304.
41. Kim, J. I., C. J. Lee, M. S. Jin, C. H. Lee, S. G. Paik, H. Lee, and J. O. Lee. 2005. Crystal structure of CD14 and its implications for lipopolysaccharide signaling. J. Biol. Chem. 280: 11347-11351. (Pubitemid 40418442)